Company's Stockholders Equity (Detail) - USD ($) $ in Thousands		3 Months Ended				6 Months Ended
		Jul. 30, 2022	Apr. 30, 2022	Jul. 31, 2021	May 01, 2021	Jul. 30, 2022	Jul. 31, 2021
Balance at beginning of period		$ 716,156	$ 760,417	$ 539,892	$ 464,754	$ 760,417	$ 464,754
Net income		11,966	16,174	102,554	171,030	$ 28,139	$ 273,584
Stock options exercised		1,230	4,721	12,811	16,089
Stock options exercised (in shares)	[1]					64,761
Shares used for tax withholding		(6,923)	(5,673)	$ (178)	(13,083)
Shares purchased as part of publicly announced program		$ (101,035)	(99,090)
Vesting of restricted shares, net of forfeitures of restricted shares		159,000		660,000		262,000	711,000
Stock based compensation		$ 17,173	16,705	$ 23,180	12,879
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		(6,769)	20,060	(5,083)	825	$ 13,291	$ (4,258)
Amount reclassified from accumulated other comprehensive income (loss) into earnings, net of related taxes		2,079	2,842	2,519	2,159	4,921	4,678
Balance at end of period		633,877	716,156	675,695	$ 539,892	633,877	675,695
Accounting Standards Update [Extensible List]					Accounting Standards Update (ASU) 2020-06
Cumulative-effect Adjustment
Balance at beginning of period				(114,761)
Balance at end of period					$ (114,761)
Common Stock
Balance at beginning of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at beginning of period (in shares)		81,800,820	81,677,315	80,897,050	80,661,453	81,677,315	80,661,453
Stock options exercised (in shares)		23,088	41,673	139,274	181,683
Vesting of restricted shares, net of forfeitures of restricted shares		83,620	81,832	5,645	53,914
Balance at end of period		$ 7	$ 7	$ 7	$ 7	$ 7	$ 7
Balance at end of period (in shares)		81,907,528	81,800,820	81,041,969	80,897,050	81,907,528	81,041,969
Additional Paid-in Capital
Balance at beginning of period		$ 1,948,980	$ 1,927,554	$ 1,706,883	$ 1,809,831	$ 1,927,554	$ 1,809,831
Stock options exercised		1,230	4,721	12,811	16,089
Stock based compensation		17,173	16,705	23,180	12,879
Balance at end of period		1,967,383	1,948,980	1,742,874	1,706,883	1,967,383	1,742,874
Additional Paid-in Capital | Cumulative-effect Adjustment
Balance at beginning of period				(131,916)
Balance at end of period					(131,916)
Accumulated (Deficit) Earnings
Balance at beginning of period		430,466	414,292	176,483	(11,702)	414,292	(11,702)
Net income		11,966	16,174	102,554	171,030
Balance at end of period		442,432	430,466	279,037	176,483	442,432	279,037
Accumulated (Deficit) Earnings | Cumulative-effect Adjustment
Balance at beginning of period				17,155
Balance at end of period					17,155
Accumulated Other Comprehensive (Loss) Income
Balance at beginning of period		18,461	(4,441)	(20,031)	(23,015)	(4,441)	(23,015)
Unrealized gains (losses) on interest rate derivative contracts, net of related taxes benefit		(6,769)	20,060	(5,083)	825
Amount reclassified from accumulated other comprehensive income (loss) into earnings, net of related taxes		2,079	2,842	2,519	2,159
Balance at end of period		13,771	18,461	(22,595)	(20,031)	13,771	(22,595)
Treasury Stock
Balance at beginning of period		$ (1,681,758)	$ (1,576,995)	$ (1,323,450)	$ (1,310,367)	$ (1,576,995)	$ (1,310,367)
Balance at beginning of period (in shares)		(15,728,755)	(15,185,760)	(14,316,890)	(14,275,122)	(15,185,760)	(14,275,122)
Shares used for tax withholding		$ (6,923)	$ (5,673)	$ (178)	$ (13,083)
Shares used for tax withholding (in shares)		(34,028)	(30,090)	(603)	(41,768)
Shares purchased as part of publicly announced program		$ (101,035)	$ (99,090)
Shares purchased as part of publicly announced program, (in shares)		(598,278)	(512,905)
Balance at end of period		$ (1,789,716)	$ (1,681,758)	$ (1,323,628)	$ (1,323,450)	$ (1,789,716)	$ (1,323,628)
Balance at end of period (in shares)		(16,361,061)	(15,728,755)	(14,317,493)	(14,316,890)	(16,361,061)	(14,317,493)

[1] Options exercised during the six month period ended July 30, 2022 had a total intrinsic value of $6.4 million.